About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Sex, Psychopharmacology, and Diabetes | Clinical Trials | Clareo Health

Back to clinical trial search

RECRUITINGNANCT05951660

Sex, Psychopharmacology, and Diabetes

The term sexual (SD) dysfunction covers conditions that prevent people from having a satisfactory sex life. SD is a frequent and sometimes debilitating complication of mental illness and a known adver...

Lead sponsor: Zealand University Hospital•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Gesche Jürgens, Clinical Professor

CONTACT

+45-93566501 [email protected]

Rikke Meyer, MD

CONTACT

+45-20419810 [email protected]

Sponsors

Lead Sponsor

Zealand University Hospital

Collaborators

Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital
Steno Diabetes Center Sjaelland
University College Copenhagen

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Age ≥ 18 years
•A diagnosis in the schizophrenic spectrum (ICD10 F2x)
•One of the following:
•1. A diagnosis of diabetes (ICD10 E10x, E11x, E12x, E13x, 14x)
•2. A current or previous prediabetes defined as an HbA1c between 39-47 mmol/mol (both included) measured in at least two blood samples collected with ≥3 months intervals as part of the patient's routine clinical monitoring
•3. Obesity defined as a Body-Mass Index (BMI) ≥30 kg/m2
•Ongoing treatment with at least one antipsychotic agent
•A SD that can be rated using Changes in Sexual Function Questionnaire-14 (CSFQ-14)

Exclusion Criteria

•Incapacitated or subject to mental health probation
•Unable to speak danish

Related studies

RECRUITINGPhase 4

Effect of Early Combination Antihyperglycemic Treatment on Metabolic Control in Individuals With Type 2 Diabetes

NCT06613854 · Type 2 Diabetes Mellitus (T2DM)

RECRUITINGPhase 1

Investigating How NNC0487-0111 Regulates Insulin of Adults With Type 2 Diabetes

NCT07535307 · Diabetes Mellitus

RECRUITINGPhase 3

A Trial of the Efficacy and Safety of SEP-363856 in Acutely Psychotic Participants With Schizophrenia

NCT06894212 · Schizophrenia

RECRUITINGPhase 2

INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetes

NCT07224321 · Type 1 Diabetes Mellitus

Measurement of Ocular Blood Flow and Retinal Oxygen Extraction in Diabetic Patients

NCT07536516 · Diabetes Mellitus

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: February 11, 2025Terms

Trial snapshot

StatusRECRUITING

PhaseNA

Enrollment256

Start dateAug 2023

Last updatedFeb 11, 2025

Condition

Schizophrenia Schizophrenia Spectrum and Other Psychotic Disorders Diabetes Mellitus PreDiabetes Sexual Dysfunction+2 more

Locations shown

Assertive Community Centres

Slagelse

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 11, 2025Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions